Work

Interactive effects of flaxseed, soy, and their phytoestrogens on MCF-7 human breast tumors and bones in ovariectomized athymic mice

Year: 2007
Type: dissertation
Abstract: Epidemiological studies suggest that phytoestrogen (PE)-rich diets are associated with a lower risk of breast cancer (BC) and osteoporosis. In experimental studies in ovariectomized (OVX) mice with MCF-7 xenografts simulating a postmenopausal situation, flaxseed (FS), rich in lignan PE, reduced tumor growth, while soy protein and its isoflavone PE, genistein (GEN), stimulated tumor growth. This thesis determined (1) if combining FS with soy can reduce the tumor growth stimulating effect of soy alone; (2) the potential mechanisms of the treatment effects; (3) if the PEs, GEN and mammalian lignans, were responsible for the effects of soy and FS; and (4) if the BC treatments can modulate bone health. OVX mice with established MCF-7 tumors were fed the basal diet, 20% soy protein isolate (SPI), 10% FS, or 20% SPI + 10% FS for 25 weeks. All treatments caused tumor regression but SPI induced late-stage tumor growth, which was attenuated when it was combined with FS. SPI increased biomarkers of tumor growth (i.e. cell proliferation, estrogen receptor (ER)alpha, cyclin D1, and pMAPK) and reduced HER2 expression. FS reduced pMAPK, and when combined with SPI, it attenuated SPI-enhanced tumor biomarkers. SPI maintained femur mineral and strength, while FS, alone and in combination with SPI, increased femur strength. Using the same model, mice with MCF-7 tumors were given daily injections (10 mg/Kg BW) of GEN, lignans (enterolactone (ENL) or enterodiol (END)), ENL+END+GEN, or vehicle control for 22 weeks. All treatments caused tumor regression but GEN caused the least effect. Like SPI, GEN increased tumor cyclin D1 and ERalpha, and also increased femur mineral and strength. Unlike FS, ENL and END increased tumor cell apoptosis but did not affect tumor pMAPK levels or preserve bone health. This suggests that the lignans, at the concentration used, may not be solely responsible for the tumor inhibitory and bone protective effects of FS. The ENL+END+GEN group did not affect biomarkers of tumor growth or preserve bone health compared to control. In conclusion, FS alone or in combination with SPI can reduce tumor growth while SPI does not. The BC therapies did not adversely affect bone health.
Language: English
Field: Nursing
Open Access status: green
OpenAlex ID: W7132923915
Cites: 296
Cited by: 1
Related to: 10